xanomeline has been researched along with carbamylcholine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christopoulos, A; El-Fakahany, EE; Pierce, TL; Sorman, JL | 1 |
Brown, F; Ho, M; Hunter, AJ; Middlemiss, DN; Murkitt, KL; Watson, JM; Wood, MD | 1 |
Bonifazi, A; Del Bello, F; Farande, A; Ferré, S; Matucci, R; Nesi, M; Petrelli, R; Piergentili, A; Quaglia, W; Vistoli, G; Yano, H | 1 |
3 other study(ies) available for xanomeline and carbamylcholine
Article | Year |
---|---|
On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.
Topics: Animals; Atropine; Carbachol; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Muscarinic Agonists; N-Methylscopolamine; Nitric Oxide Synthase; Phosphatidylinositols; Pyridines; Receptor, Muscarinic M1; Receptors, Muscarinic; Thiadiazoles; Time Factors | 1998 |
Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
Topics: Animals; CHO Cells; Cricetinae; Humans; Muscarinic Agonists; Quinuclidinyl Benzilate; Radioligand Assay; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptor, Muscarinic M4; Receptors, Muscarinic | 1999 |
Synthesis and biological evaluation of a novel series of heterobivalent muscarinic ligands based on xanomeline and 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).
Topics: Animals; CHO Cells; Cricetulus; Molecular Docking Simulation; Muscarinic Agonists; Piperidines; Pyridines; Quinolones; Receptor, Muscarinic M1; Structure-Activity Relationship; Thiadiazoles | 2014 |